Dapa CKD - A study to evaluate the effect of Dapaglifozin on renal outcomes and cardiovascular mortality in patients with chronic kidney disease (D169AC00001) - CONVERIS Research Information System by Thomson Reuters:

Go to Header Go to Navigation Go to Content Go to Footer

Title: Dapa CKD - A study to evaluate the effect of Dapaglifozin on renal outcomes and cardiovascular mortality in patients with chronic kidney disease (D169AC00001)

Funder
Cardiff & Vale University Health Board

Principal Investigator

Fraser, Donald

Project Details

Net value award figure for Cardiff University: £6,011.00

Start date: 03/08/2017

End date: 31/08/2021

Our policy towards the use of cookies